MRP ₹183.5
(Inclusive of all Taxes)
₹27.5 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
OUTPUT:```Composition :
क्लोरथैलिडोन-१२.५एमजी + टेलिमिसर्टन-८०एमजी
Manufacturer/Marketer :
माइक्रो लैब्स लिमिटेड
Consume Type :
मौखिक
Return Policy :
वापसी योग्य नहीं
Expires on or after :
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Co-administration of Aliskiren with Telfirst-CT 40 mg/6.25 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Telfirst-CT 40 mg/6.25 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Co-administration of Telfirst-CT 40 mg/6.25 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Telfirst-CT 40 mg/6.25 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Co-administration of amiloride with Telfirst-CT 40 mg/6.25 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Telfirst-CT 40 mg/6.25 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Co-administration of Potassium acetate can make Telfirst-CT 40 mg/6.25 mg Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Telfirst-CT 40 mg/6.25 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Telfirst-CT 40 mg/6.25 mg Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Telfirst-CT 40 mg/6.25 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Coadministration of enalapril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telfirst-CT 40 mg/6.25 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telfirst-CT 40 mg/6.25 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Co-administration of Telfirst-CT 40 mg/6.25 mg Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Telfirst-CT 40 mg/6.25 mg Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Taking perindopril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Taking Potassium citrate with Telfirst-CT 40 mg/6.25 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telfirst-CT 40 mg/6.25 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Telfirst-CT 40 mg/6.25 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telfirst-CT 40 mg/6.25 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Taking lisinopril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Severe
How does the drug interact with Telfirst-CT 40 mg/6.25 mg Tablet:
Taking quinapril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Telfirst-CT 40 mg/6.25 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40 mg/6.25 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Telfirst-CT 40 mg/6.25 mg Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telfirst-CT 40 mg/6.25 mg Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Telfirst-CT 40 mg/6.25 mg Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
All Substitutes & Brand Comparisons
RX
Telmiride-CH 40 mg/6.25 mg Tablet 10's
Unison Pharmaceuticals Pvt Ltd
₹33.5
(₹3.02 per unit)
81% CHEAPERRX
Cresar CT 6.25 Tablet 10's
Cipla Ltd
₹67.5
(₹6.08 per unit)
63% CHEAPERRX
Telmikind-CT 40/6.25 Tablet 10's
Mankind Pharma Pvt Ltd
₹71
(₹6.39 per unit)
61% CHEAPER
Alcohol
Unsafe
आपको सलाह दी जाती है कि आप शराब का सेवन न करें और टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 उनींदापन, चक्कर आना और लीवर की क्षति जैसे अप्रिय दुष्प्रभावों से बचें।
Pregnancy
Unsafe
गर्भावस्था के दौरान टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 की सलाह नहीं दी जाती है क्योंकि यह गर्भावस्था की श्रेणी D की दवा है। यह दवा भ्रूण को नुकसान पहुंचा सकती है और अजन्मे बच्चे (भ्रूण) को प्रभावित कर सकती है।
Breast Feeding
Unsafe
टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 के स्तन के दूध में जाने के बारे में जाना जाता है, लेकिन बच्चे पर इसका प्रभाव ज्ञात नहीं है। इसलिए, स्तनपान कराने से पहले, अपने डॉक्टर को इस बारे में बताएं। या तो आपको टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 का उपयोग करने के लिए स्तनपान बंद करना होगा, या आपको टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 लेना बंद करना होगा।
Driving
Unsafe
सावधानी से गाड़ी चलाएँ, टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 आमतौर पर उनींदापन का कारण बनता है और ड्राइविंग क्षमता को प्रभावित करता है।
Liver
Caution
सावधानी के साथ लेने के लिए टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10, खासकर यदि आपको लीवर की बीमारी का इतिहास रहा है। आपका डॉक्टर आपकी चिकित्सीय स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक को बदलेगा।
Kidney
Unsafe
पुरानी किडनी की बीमारी (गंभीर गुर्दे की हानि) के रोगियों में अनुशंसित नहीं है। गंभीर गुर्दे की हानि वाले रोगियों में सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Children
Caution
बच्चों में टेलफर्स्ट-सीटी 40 मिलीग्राम/6.25 मिलीग्राम टैबलेट 10 की प्रभावकारिता और सुरक्षा स्थापित नहीं की गई है। यदि निर्धारित किया जाता है, तो यह कड़ाई से चिकित्सीय देखरेख में होना चाहिए और केवल तभी जब लाभ नुकसान से अधिक हो।
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
